Endocannabinoid receptor deficiency affects maternal care and alters the dam's hippocampal oxytocin receptor and brain-derived neurotrophic factor expression

Journal of Neuroendocrinology

Volumn 25, Issue 10, 2013, Pages 898-909

  Schechter, M ^a,b   Weller, A ^b   Pittel, Z ^a   Gross, M ^a   Zimmer, A ^c   Pinhasov, A ^a  

^a ARIEL UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Brain derived neurotrophic factor; CB1 receptor; Corticosterone; Endocannabinoid system; Maternal care; Oxytocin receptor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; ENDOCANNABINOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; OXYTOCIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ECHOGRAPHY; FEMALE; FETUS; HIPPOCAMPUS; MATERNAL BEHAVIOR; MATERNAL CARE; MOTHER CHILD RELATION; MOUSE; NONHUMAN; NULLIPARA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERPERIUM; STRESS; VOCALIZATION;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CB1 RECEPTOR; CORTICOSTERONE; ENDOCANNABINOID SYSTEM; MATERNAL CARE; OXYTOCIN RECEPTOR;

ANIMALS; BASE SEQUENCE; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA PRIMERS; FEMALE; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; OXYTOCIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CANNABINOID; RECEPTORS, OXYTOCIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84883813418     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12082     Document Type: Article

References (81)

1. Swain JE, Lorberbaum JP, Kose S, Strathearn L. Brain basis of early parent-infant interactions: psychology, physiology, and in vivo functional neuroimaging studies. J Child Psychol Psychiatry 2007; 48: 262-287.
2. Saltzman W, Maestripieri D. The neuroendocrinology of primate maternal behavior. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1192-1204.
3. Nemsadze K, Silagava M. Neuroendocrine foundation of maternal-child attachment. Georgian Med News 2010; 189: 21-26.
4. Saltzman W, Abbott DH. Diminished maternal responsiveness during pregnancy in multiparous female common marmosets. Horm Behav 2005; 47: 151-163.
5. Bridges RS, Ronsheim PM. Prolactin (PRL) regulation of maternal behavior in rats: bromocriptine treatment delays and PRL promotes the rapid onset of behavior. Endocrinology 1990; 126: 837-848.
6. Onaka T, Takayanagi Y, Yoshida M. Roles of oxytocin neurones in the control of stress, energy metabolism, and social behaviour. J Neuroendocrinol 2012; 24: 587-598.
7. Klaus M. Mother and infant: early emotional ties. Pediatrics 1998; 5(Suppl. E): 1244-1246.
8. Neumann ID. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J Neuroendocrinol 2008; 20: 858-865.
9. Bosch OJ, Neumann ID. Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety. Proc Natl Acad Sci USA 2008; 105: 17139-17144.
10. Lim MM, Young LJ. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm Behav 2006; 50: 506-517.
11. Heinrichs M, von Dawans B, Domes G. Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol 2009; 30: 548-557.
12. Byrnes EM, Rigero BA, Bridges RS. Dopamine antagonists during parturition disrupt maternal care and the retention of maternal behavior in rats. Pharmacol Biochem Behav 2002; 73: 869-875.
13. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol 2000; 11: 279-290.
14. Champagne FA, Chretien P, Stevenson CW, Zhang TY, Gratton A, Meaney MJ. Variations in nucleus accumbens dopamine associated with individual differences in maternal behavior in the rat. J Neurosci 2004; 24: 4113-4123.
15. Woolley CS. Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm Behav 1998; 34: 140-148.
16. Rudick CN, Woolley CS. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 2001; 21: 6532-6543.
17. Champagne DL, Bagot RC, van Hasselt F, Ramakers G, Meaney MJ, de Kloet ER, Joels M, Krugers H. Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning, and differential responsiveness to glucocorticoids and stress. J Neurosci 2008; 28: 6037-6045.
18. Hellstrom IC, Dhir SK, Diorio JC, Meaney MJ. Maternal licking regulates hippocampal glucocorticoid receptor transcription through a thyroid hormone-serotonin-NGFI-A signalling cascade. Philos Trans R Soc Lond B Biol Sci 2012; 367: 2495-2510.
19. Valverde O, Karsak M, Zimmer A. Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice. Handb Exp Pharmacol 2005; 168: 117-145.
20. Valverde O. Participation of the cannabinoid system in the regulation of emotional-like behaviour. Curr Pharm Des 2005; 11: 3421-3429.
21. Sabatier N, Leng G. Presynaptic actions of endocannabinoids mediate alpha-MSH-induced inhibition of oxytocin cells. Am J Physiol Regul Integr Comp Physiol 2006; 290: R577-R584.
22. Chaperon F, Thiebot MH. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 1999; 13: 243-281.
23. Maccarrone M, Valverde O, Barbaccia ML, Castane A, Maldonado R, Ledent C, Parmentier M, Finazzi-Agro A. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci 2002; 15: 1178-1186.
24. Haller J, Varga B, Ledent C, Barna I, Freund TF. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 2004; 19: 1906-1912.
25. Aso E, Ozaita A, Valdizan EM, Ledent C, Pazos A, Maldonado R, Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem 2008; 105: 565-572.
26. Aso E, Ozaita A, Serra M-À, Maldonado R. Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype. Eur Neuropsychopharmacol 2011; 21: 11-22.
27. Valverde O, Torrens M. CB1 receptor-deficient mice as a model for depression. Neuroscience 2012; 204: 193-206.
28. Fong TM, Heymsfield SB. Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions. Int J Obes 2009; 33: 947-955.
29. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. NeuroReport 1997; 8: 491-496.
30. Schechter M, Pinhasov A, Weller A, Fride E. Blocking the postpartum mouse dam's CB1 receptors impairs maternal behavior as well as offspring development and their adult social-emotional behavior. Behav Brain Res 2012; 226: 481-492.
31. Herman JP, Tasker JG, Ziegler DR, Cullinan WE. Local circuit regulation of paraventricular nucleus stress integration: glutamate-GABA connections. Pharmacol Biochem Behav 2002; 71: 457-468.
32. de Kloet ER. About stress hormones and resilience to psychopathology. J Neuroendocrinol 2008; 20: 885-892.
33. Hill MN, Hunter RG, McEwen BS. Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields. Eur J Pharmacol 2009; 614: 66-69.
34. Malcher-Lopes R, Di S, Marcheselli VS, Weng FJ, Stuart CT, Bazan NG, Tasker JG. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci 2006; 26: 6643-6650.
35. Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology 2010; 35: 1333-1338.
36. Butovsky E, Juknat A, Elbaz J, Shabat-Simon M, Eilam R, Zangen A, Altstein M, Vogel Z. Chronic exposure to Delta9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas. Mol Cell Neurosci 2006; 31: 795-804.
37. Schneider M, Koch M. Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology 2005; 30: 944-957.
38. Insel TR, Young LJ. The neurobiology of attachment. Nat Rev Neurosci 2001; 2: 129-136.
39. Pedersen CA. Oxytocin control of maternal behavior. Regulation by sex steroids and offspring stimuli. Ann NY Acad Sci 1997; 807: 126-145.
40. Gazal M, Motta L, Wiener C, Fernandes J, Quevedo L, Jansen K, Pinheiro K, Giovenardi M, Souza D, Azevedo daSilva R, Pinheiro R, Portela L, Oses J. Brain-derived neurotrophic factor in post-partum depressive mothers. Neurochem Res 2012; 37: 583-587.
41. Wisner KL, Chambers C, Sit DK. Postpartum depression: a major public health problem. JAMA: The Journal of the American Medical Association 2006; 296: 2616-2618.
42. Moreno G, Piermaria J, Gaillard RC, Spinedi E. In vitro functionality of isolated embryonic hypothalamic vasopressinergic and oxytocinergic neurons: modulatory effects of brain-derived neurotrophic factor and angiotensin II. Endocrine 2011; 39: 83-88.
43. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 1999; 96: 5780-5785.
44. Winslow JT, Hearn EF, Ferguson J, Young LJ, Matzuk MM, Insel TR. Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Horm Behav 2000; 37: 145-155.
45. Pinhasov A, Ilyin SE, Crooke J, Amato FA, Vaidya AH, Rosenthal D, Brenneman DE, Malatynska E. Different levels of gamma-synuclein mRNA in the cerebral cortex of dominant, neutral and submissive rats selected in the competition test. Genes Brain Behav 2005; 4: 60-64.
46. Shneider Y, Shtrauss Y, Yadid G, Pinhasov A. Differential expression of PACAP receptors in postnatal rat brain. Neuropeptides 2010; 44: 509-514.
47. Cohen-Salmon C. Differences in patterns of pup care in Mus musculus domesticus. VIII. Effects of previous experience and parity in XLII inbred mice. Physiol Behav 1987; 40: 177-180.
48. Scattoni ML, Crawley J, Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev 2009; 33: 508-515.
49. D'Amato FR, Scalera E, Sarli C, Moles A. Pups call, mothers rush: does maternal responsiveness affect the amount of ultrasonic vocalizations in mouse pups? Behav Genet 2005; 35: 103-112.
50. Shahrokh DK, Zhang TY, Diorio J, Gratton A, Meaney MJ. Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 2010; 151: 2276-2286.
51. Pedersen CA, Boccia ML. Oxytocin links mothering received, mothering bestowed and adult stress responses. Stress 2002; 5: 259-267.
52. Numan M. Hypothalamic neural circuits regulating maternal responsiveness toward infants. Behav Cogn Neurosci Rev 2006; 5: 163-190.
53. Neumann ID, Johnstone HA, Hatzinger M, Liebsch G, Shipston M, Russell JA, Landgraf R, Douglas AJ. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes. J Physiol 1998; 508: 289-300.
54. Smith CD, Lonstein JS. Contact with infants modulates anxiety-generated c-fos activity in the brains of postpartum rats. Behav Brain Res 2008; 190: 193-200.
55. Smotherman WP, Wiener SG, Mendoza SP, Levine S. Pituitary-adrenal responsiveness of rat mothers to noxious stimuli and stimuli produced by pups. Ciba Found Symp 1976; 45: 5-25.
56. Higuchi T, Honda K, Fukuoka T, Negoro H, Wakabayashi K. Release of oxytocin during suckling and parturition in the rat. J Endocrinol 1985; 105: 339-346.
57. Feldman R, Gordon I, Influs M, Gutbir T, Ebstein RP. Parental oxytocin and early caregiving jointly shape children's oxytocin response and social reciprocity. Neuropsychopharmacology 2013; 38: 1154-1162.
58. Kinsley CH, Meyer EA. The construction of the maternal brain: theoretical comment on Kim et al. (2010). Behav Neurosci 2010; 124: 710-714.
59. Carter CS. Developmental consequences of oxytocin. Physiol Behav 2003; 79: 383-397.
60. Neumann ID, Wigger A, Torner L, Holsboer F, Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J Neuroendocrinol 2000; 12: 235-243.
61. Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 2010; 30: 14980-14986.
62. Herman JP, Cullinan WE, Ziegler DR, Tasker JG. Role of the paraventricular nucleus microenvironment in stress integration. Eur J Neurosci 2002; 16: 381-385.
63. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003; 23: 4850-4857.
64. Di S, Malcher-Lopes R, Marcheselli VL, Bazan NG, Tasker JG. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 2005; 146: 4292-4301.
65. Evanson NK, Tasker JG, Hill MN, Hillard CJ, Herman JP. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 2010; 151: 4811-4819.
66. Fride E, Suris R, Weidenfeld J, Mechoulam R. Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice. Behav Pharmacol 2005; 16: 431-440.
67. Steiner MA, Marsicano G, Nestler EJ, Holsboer F, Lutz B, Wotjak CT. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 2008; 33: 54-67.
68. de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6: 463-475.
69. Atkinson HC, Waddell BJ. The hypothalamic-pituitary-adrenal axis in rat pregnancy and lactation: circadian variation and interrelationship of plasma adrenocorticotropin and corticosterone. Endocrinology 1995; 136: 512-520.
70. Catalani A, Alema GS, Cinque C, Zuena AR, Casolini P. Maternal corticosterone effects on hypothalamus-pituitary-adrenal axis regulation and behavior of the offspring in rodents. Neurosci Biobehav Rev 2011; 35: 1502-1517.
71. Slattery DA, Neumann ID. No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. J Physiol 2008; 586: 377-385.
72. Urigüen L, Pérez-Rial S, Ledent C, Palomo T, Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 2004; 46: 966-973.
73. Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grubler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007; 148: 1574-1581.
74. Atkinson HC, Leggett JD, Wood SA, Castrique ES, Kershaw YM, Lightman SL. Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic. Endocrinology 2010; 151: 3720-3727.
75. Pinhasov A, Nesher E, Gross M, Turgeman G, Kreinin A, Yadid G. The role of the PACAP signaling system in depression. Curr Pharm Des 2011; 17: 990-1001.
76. Moussaieff A, Gross M, Nesher E, Tikhonov T, Yadid G, Pinhasov A. Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals. J Psychopharmacol 2012; 26: 1584-1593.
77. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Reperant C, Guilloux JP, Coudore F, Hen R, Gardier AM. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008; 55: 1006-1014.
78. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.
79. Reichenstein M, Rehavi M, Pinhasov A. Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action. J Mol Neurosci 2008; 36: 330-338.
80. Jacobsen JPR, Mørk A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res 2006; 1110: 221-225.
81. Zoratto F, Berry A, Anzidei F, Fiore M, Alleva E, Laviola G, Macrì S. Effects of maternal l-tryptophan depletion and corticosterone administration on neurobehavioral adjustments in mouse dams and their adolescent and adult daughters. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1479-1492.